Suppressive action of resolvin D1 on the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Experimental and Therapeutic Medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ETM.2010.170PMID 22977469PMCID PMC3440633
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resolvin D1 binds human phagocytes with evidence for proresolving receptors

  2010cited by this paper
• Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators

  2008cited by this paper
• Endogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genus

  2008cited by this paper
• Resolvin E1 Selectively Interacts with Leukotriene B4 Receptor BLT1 and ChemR23 to Regulate Inflammation1

  2007cited by this paper
• Resolvin D1 and Its Aspirin-triggered 17R Epimer

  2007influential reference
• Resolvin D Series and Protectin D1 Mitigate Acute Kidney Injury1

  2006cited by this paper
• Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators.

  2006cited by this paper
• HMGB1: guiding immunity from within.

  2005cited by this paper
• Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

  2005cited by this paper
• The cytokine activity of HMGB1

  2005cited by this paper
• Extracellular role of HMGB1 in inflammation and sepsis

  2004cited by this paper
• The enigma of sepsis.

  2003cited by this paper
• Novel strategies for the treatment of sepsis

  2003cited by this paper
• Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock

  2003cited by this paper
• Activation of gene expression in human neutrophils by high mobility group box 1 protein.

  2003cited by this paper
• Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells.

  2003cited by this paper
• Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

  2003cited by this paper
• The immunopathogenesis of sepsis

  2002cited by this paper
• HMGB1 as a late mediator of lethal systemic inflammation.

  2001cited by this paper
• High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes

  2000cited by this paper
• HMG-1 as a late mediator of endotoxin lethality in mice.

  1999cited by this paper
• TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.

  1996cited by this paper
• Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models.

  1995cited by this paper
• Galactosamine-induced sensitization to the lethal effects of endotoxin.

  1979cited by this paper

• Pharmacological effects of specialized pro-resolving mediators in sepsis-induced organ dysfunction: a narrative review

  2024cites this paper
• Resolvin D1 (Rvd1) Attenuates In Vitro LPS-Stimulated Inflammation Through Downregulation of miR-155, miR -146, miR -148 and Krupple Like Factor 5.

  2024cites this paper
• Resolution pharmacology and the treatment of infectious diseases

  2024cites this paper
• Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development

  2023cites this paper
• P2Y2 purinergic receptor gene deletion protects mice from bacterial endotoxin and sepsis-associated liver injury and mortality.

  2023cites this paper
• Formyl peptide receptor 2 is an emerging modulator of inflammation in the liver

  2023cites this paper
• Lipids in Liver Failure Syndromes: A Focus on Eicosanoids, Specialized Pro-Resolving Lipid Mediators and Lysophospholipids

  2022cites this paper
• Resolvin D1 attenuated liver injury caused by chronic ethanol and acute LPS challenge in mice

  2022cites this paper
• The role of Resolvin D1 in liver diseases.

  2022cites this paper
• Proresolving lipid mediators and liver disease.

  2021cites this paper
• Specialized pro‐resolving mediators: biosynthesis and biological role in bacterial infections

  2021cites this paper
• Omega 3 Fatty Acid and Skin Diseases

  2021cites this paper
• Resolvin D1 activates the sphingosine-1-phosphate signaling pathway in murine livers with ischemia/reperfusion injury.

  2019cites this paper
• Resolvin D1 Attenuates the Organ Injury Associated With Experimental Hemorrhagic Shock

  2019cites this paper
• Pro-resolution of Inflammation: New Hints to Manage Sepsis?

  2019influential citation
• ResolvinD1 attenuates high-mobility group box 1-induced epithelial-to-mesenchymal transition in nasopharyngeal carcinoma cells

  2019influential citation
• Pro-Resolving Molecules—New Approaches to Treat Sepsis?

  2017cites this paper
• Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases

  2017cites this paper
• The lipoxin A4 agonist BML-111 attenuates acute hepatic dysfunction induced by cecal ligation and puncture in rats

  2016cites this paper
• The anti-inflammatory and pro-resolution effects of aspirin-triggered RvD1 (AT-RvD1) on peripheral blood mononuclear cells from patients with severe asthma.

  2016cites this paper
• Release mechanism of high mobility group nucleosome binding domain 1 from lipopolysaccharide-stimulated macrophages.

  2016cites this paper
• Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes

  2016cites this paper
• Lipid mediators in the resolution of inflammation.

  2015cites this paper
• Roles of resolvins in the resolution of acute inflammation

  2015cites this paper
• Aspirin-Triggered Resolvin D1 Versus Dexamethasone in the Treatment of Sjögren's Syndrome-Like NOD/ShiLtJ Mice - A Pilot Study.

  2015cites this paper
• High-mobility group box 1 suppresses resolvin D1-induced phagocytosis via induction of resolvin D1-inactivating enzyme, 15-hydroxyprostaglandin dehydrogenase.

  2015cites this paper
• Acanthopanax senticosus attenuates inflammation in lipopolysaccharide-induced acute lung injury by inhibiting the NF-κB pathway.

  2014cites this paper
• HMGB1 in health and disease.

  2014cites this paper
• Macrophages: Biology and Role in the Pathology of Diseases

  2014cites this paper
• Macrophages and the Entrance of Resolution Phase Lipid Mediators

  2014cites this paper
• [What the surgeon needs to know about basic new concepts of inflammation and their therapeutic consequences: sanitation of inflammation is not a passive but rather an active process regulated by lipid mediators].

  2013cites this paper
• A polysaccharide isolated from the liquid culture of Lentinus edodes (Shiitake) mushroom mycelia containing black rice bran protects mice against a Salmonella lipopolysaccharide-induced endotoxemia.

  2013cites this paper
• Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules?

  2012cites this paper
• Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway

  2012cites this paper